<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK169003" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK169003/" /><meta name="ncbi_pagename" content="Hepatoerythropoietic Porphyria - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hepatoerythropoietic Porphyria - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hepatoerythropoietic Porphyria" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/12/22" /><meta name="citation_author" content="Lawrence U Liu" /><meta name="citation_author" content="John Phillips" /><meta name="citation_author" content="Herbert Bonkovsky" /><meta name="citation_author" content="Porphyrias Consortium of the Rare Diseases Clinical Research Network" /><meta name="citation_pmid" content="24175354" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK169003/" /><meta name="citation_keywords" content="Uroporphyrinogen decarboxylase" /><meta name="citation_keywords" content="UROD" /><meta name="citation_keywords" content="Hepatoerythropoietic Porphyria" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hepatoerythropoietic Porphyria" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lawrence U Liu" /><meta name="DC.Contributor" content="John Phillips" /><meta name="DC.Contributor" content="Herbert Bonkovsky" /><meta name="DC.Contributor" content="Porphyrias Consortium of the Rare Diseases Clinical Research Network" /><meta name="DC.Date" content="2016/12/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK169003/" /><meta name="description" content="Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, and scarring over the affected skin areas. Disease manifestations occur during infancy or childhood and with similar frequency in females and males. Individuals with HEP are not reported to be at increased risk for hepatocellular carcinoma." /><meta name="og:title" content="Hepatoerythropoietic Porphyria" /><meta name="og:type" content="book" /><meta name="og:description" content="Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, and scarring over the affected skin areas. Disease manifestations occur during infancy or childhood and with similar frequency in females and males. Individuals with HEP are not reported to be at increased risk for hepatocellular carcinoma." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK169003/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hep/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK169003/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AFD22E03FC7110000000009290310.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK169003_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK169003_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vodi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ataxias/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK169003_"><span class="title" itemprop="name">Hepatoerythropoietic Porphyria</span></h1><p class="contrib-group"><span itemprop="author">Lawrence U Liu</span>, MD, <span itemprop="author">John Phillips</span>, PhD, <span itemprop="author">Herbert Bonkovsky</span>, MD; <span itemprop="author">Porphyrias Consortium of the Rare Diseases Clinical Research Network</span>.</p><a data-jig="ncbitoggler" href="#__NBK169003_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK169003_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lawrence U Liu</span>, MD<div class="affiliation small">Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.ianistnuom@uil.ecnerwal" class="oemail">gro.ianistnuom@uil.ecnerwal</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">John Phillips</span>, PhD<div class="affiliation small">University of Utah School of Medicine<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hatu.csh@spillihp.nhoj" class="oemail">ude.hatu.csh@spillihp.nhoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Herbert Bonkovsky</span>, MD<div class="affiliation small">Wake Forest University School of Medicine and North Carolina Baptist Medical Center<br />Winston-Salem, North Carolina</div><div class="affiliation small">University of North Carolina at Chapel Hill<br />University of Connecticut<br />Farmington, Connecticut<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.em@yksvoknobh" class="oemail">moc.em@yksvoknobh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Porphyrias Consortium of the Rare Diseases Clinical Research Network</span><sup><a href="#hep.Tb.an4" class="bk_pop">*</a></sup></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 31, 2013</span>; Last Update: <span itemprop="dateModified">December 22, 2016</span>.</p><p><em>Estimated reading time: 13 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hep.Summary" itemprop="description"><h2 id="_hep_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, and scarring over the affected skin areas. Disease manifestations occur during infancy or childhood and with similar frequency in females and males. Individuals with HEP are not reported to be at increased risk for hepatocellular carcinoma.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HEP is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of elevated porphyrins in the urine (predominantly uroporphyrin and heptacarboxylporphyrin) and significantly increased erythrocyte zinc protoporphyrin. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>UROD</i> confirms the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Avoidance of sunlight (including the long-wave ultraviolet light sunlight that passes through window glass) by use of protective clothing and topical application of opaque sunscreens. Phlebotomy and chloroquine, which are usually effective in treating <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda, are generally less effective in individuals with HEP.</p><p><i>Prevention of primary manifestations:</i> Protection from sunlight.</p><p><i>Agents/circumstances to avoid:</i> Exposure to sunlight in persons of all ages. Older individuals should avoid known precipitating factors: alcohol, oral estrogen, smoking, and drugs that induce the cytochrome P450s.</p><p><i>Evaluation of relatives at risk:</i> If the family-specific <i>UROD</i> pathogenic variants are known, clarify the genetic status of at-risk relatives so that those with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>UROD</i> pathogenic variants can be counseled regarding sun protection and avoidance of known susceptibility factors.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>HEP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and at risk of developing <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda, and a 25% chance of being unaffected and not heterozygous. Once the <i>UROD</i> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HEP are possible.</p></div></div><div id="hep.Diagnosis"><h2 id="_hep_Diagnosis_">Diagnosis</h2><div id="hep.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Hepatoerythropoietic porphyria (HEP) <b>should be considered</b> in individuals who present during infancy or childhood with the following clinical features and laboratory findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Blistering skin lesions</div></li><li class="half_rhythm"><div>Hypertrichosis</div></li><li class="half_rhythm"><div>Scarring</div></li><li class="half_rhythm"><div>Passage of red urine</div></li></ul><p>Note: The features of HEP generally resemble those of <a href="/books/n/gene/cep/">congenital erythropoietic porphyria</a>.</p><p><b>Laboratory findings</b> (see <a class="figpopup" href="/books/NBK169003/table/hep.T.biochemical_characteristics_of_hep/?report=objectonly" target="object" rid-figpopup="fighepTbiochemicalcharacteristicsofhep" rid-ob="figobhepTbiochemicalcharacteristicsofhep">Table 1</a>)</p><ul><li class="half_rhythm"><div>Hepatic uroporphyrinogen decarboxylase (UROD) enzyme activity is approximately 15%-20% of normal.</div></li><li class="half_rhythm"><div>The UROD protein level is determined by <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> (e.g., ~50% in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and a partial <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> allele).</div></li><li class="half_rhythm"><div>Erythrocyte zinc protoporphyrin levels are significantly increased.</div></li><li class="half_rhythm"><div>Plasma porphyrins are increased. Fluorescence emission peaks (at neutral pH) at approximately 620 nm following excitation with light of approximately 400-410 nm (Soret band) [<a class="bk_pop" href="#hep.REF.pohfitzpatrick.1976.362">Poh-Fitzpatrick &#x00026; Lamola 1976</a>].</div></li><li class="half_rhythm"><div>Porphyrins are elevated in the urine. There is a predominance of uroporphyrin and heptacarboxylporphyrin; hexa- and pentacarboxylporphyrins and coproporphyrin levels are also increased. Note: Isomer analysis of the uroporphyrin shows a significant increase in isomer I uroporphyrin.</div></li><li class="half_rhythm"><div>Levels of fecal isocoproporphyrin and hepta- and pentaporphyrins are increased.</div></li><li class="half_rhythm"><div>Urine delta-aminolevulinic acid (ALA) is normal or minimally increased.</div></li><li class="half_rhythm"><div>Porphobilinogen (PBG) levels are normal.</div></li></ul><div id="hep.T.biochemical_characteristics_of_hep" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Biochemical Characteristics of Hepatoerythropoietic Porphyria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169003/table/hep.T.biochemical_characteristics_of_hep/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hep.T.biochemical_characteristics_of_hep_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biochemical Finding</th></tr></thead><tbody><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Deficient enzyme</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Uroporphyrinogen decarboxylase</td></tr><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Enzyme activity</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~15%-20% of normal</td></tr><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Erythrocytes</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; Zinc protoporphyrin</td></tr><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Plasma</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; Uroporphyrin, heptacarboxylporphyrin (~620 nm)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Urine</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; Uroporphyrin, heptacarboxylporphyrin</td></tr><tr><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Stool</b></td><td headers="hd_h_hep.T.biochemical_characteristics_of_hep_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; Heptacarboxylporphyrin, isocoproporphyrins + pentacarboxylporphyrins</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hep.TF.1.1"><p class="no_margin">Fluorescence emission peak of diluted plasma at neutral pH, following excitation at 400-410 nm</p></div></dd></dl></div></div></div><p>Note: Histologic findings on skin biopsy are not diagnostic of HEP.</p></div><div id="hep.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of HEP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the presence of increased uroporphyrin and heptacarboylporphyrin in the urine in addition to significantly increased erythrocyte zinc protoporphyrin, and/or by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>UROD</i> (see <a class="figpopup" href="/books/NBK169003/table/hep.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="fighepTmoleculargenetictestingusedin" rid-ob="figobhepTmoleculargenetictestingusedin">Table 2</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>UROD</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>UROD</i> and other genes of interest (see <a href="#hep.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>UROD</i>) fails to confirm a diagnosis in an individual with features of HEP. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="hep.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hepatoerythropoietic Porphyria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169003/table/hep.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hep.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>UROD</i></td><td headers="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/16&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_hep.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/16&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hep.TF.2.1"><p class="no_margin">See <a href="/books/NBK169003/#hep.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hep.TF.2.2"><p class="no_margin">See <a href="#hep.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="hep.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="hep.TF.2.4"><p class="no_margin">Author communication</p></div></dd><dt>5. </dt><dd><div id="hep.TF.2.5"><p class="no_margin">Additional variants associated with F-PTC have been detected.</p></div></dd><dt>6. </dt><dd><div id="hep.TF.2.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="hep.TF.2.7"><p class="no_margin">Large deletions involving <i>UROD</i> have been described in HEP, including <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in one individual [<a class="bk_pop" href="#hep.REF.de_verneuil.1992.548">de Verneuil et al 1992</a>] and a 1-kb deletion in another [<a class="bk_pop" href="#hep.REF.mendez.1998.1363">Mendez et al 1998</a>]. <a class="bk_pop" href="#hep.REF.cantatorefrancis.2010.529">Cantatore-Francis et al [2010]</a> described compound heterozygosity for a complex deletion/<a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant.</p></div></dd></dl></div></div></div></div></div><div id="hep.Clinical_Characteristics"><h2 id="_hep_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hep.Clinical_Description"><h3>Clinical Description</h3><p>Clinical manifestations of HEP include extreme photosensitivity, skin lesions with fluid-filled blisters that break and heal slowly, hypertrichosis, and scarring over the affected skin areas. Repeated sun exposure can lead to scleroderma-like changes that result in photomutilation [<a class="bk_pop" href="#hep.REF.elder.1997.237">Elder 1997</a>]. With high levels of circulating porphyrins there may be a red/brown discoloration of teeth due to the deposition of porphyrins in the enamal layer of the developing tooth. Signs and symptoms of HEP start during infancy or childhood, with similar frequency in females and males, and generally resemble those of <a href="/books/n/gene/cep/">congenital erythropoietic porphyria</a>. Note: The clinical features of <a href="/books/n/gene/porphyria-ct/">porphyria cutanea tarda</a> (PCT) (see <a href="#hep.Differential_Diagnosis">Differential Diagnosis</a>) and HEP are indistinguishable.</p><p>No increased risk for hepatocellular carcinoma has been identified in persons with HEP.</p><p><b>Susceptibility factors.</b> The rare nature of this disease makes identification of additional risk factors difficult to assess; however, the same susceptibility factors shown to modulate the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda (F-PCT) are likely to be important in HEP (see <a href="#hep.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#hep.REF.bonkovsky.2013">Bonkovsky et al 2013</a>].</p><p>Susceptibility factors to some extent reflect their frequency in the general population to which the individual belongs. The frequency and the degree to which these risk factors are involved in type I PCT (<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>) and <a href="/books/n/gene/porphyria-ct/">F-PCT</a> also differ in HEP [<a class="bk_pop" href="#hep.REF.aarsand.2009.795">Aarsand et al 2009</a>, <a class="bk_pop" href="#hep.REF.mu_ozsantos.2010.69">Mu&#x000f1;oz-Santos et al 2010</a>].</p><p>The genetic and environmental susceptibility factors may reflect their frequency in the general population (e.g., hepatitis C infection, <i>HFE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</p><ul><li class="half_rhythm"><div><b>Iron and <i>HFE</i> pathogenic variants.</b> Mild-to-moderate iron overload is typically found in persons with F-PCT; some degree of hepatic siderosis is seen in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div><b>Alcohol.</b> PCT has long been associated with excessive alcohol use.</div></li><li class="half_rhythm"><div><b>Smoking and cytochrome P450 enzymes.</b> Smoking is commonly associated with alcohol use in PCT [<a class="bk_pop" href="#hep.REF.egger.2002.419">Egger et al 2002</a>].</div></li><li class="half_rhythm"><div><b>Hepatitis C.</b> Reported prevalence of hepatitis C in individuals with PCT has ranged from 21% to 92% in various countries [<a class="bk_pop" href="#hep.REF.ryan_caballes.2012.880">Ryan Caballes et al 2012</a>]; it is seen more frequently in type I PCT than in <a href="/books/n/gene/porphyria-ct/">F- PCT</a> [<a class="bk_pop" href="#hep.REF.mu_ozsantos.2010.69">Mu&#x000f1;oz-Santos et al 2010</a>]. Note that the frequency in HEP has not been determined.</div></li><li class="half_rhythm"><div><b>Estrogens.</b> Estrogen use is a common susceptibility factor in women with PCT [<a class="bk_pop" href="#hep.REF.grossman.1979.277">Grossman et al 1979</a>, <a class="bk_pop" href="#hep.REF.sixeldietrich.1985.13">Sixel-Dietrich &#x00026; Doss 1985</a>, <a class="bk_pop" href="#hep.REF.egger.2002.419">Egger et al 2002</a>] and also presents a risk for men (e.g., those taking estrogen for treatment of prostatic cancer). Discontinuation of oral estrogen use leads to resolution of the symptoms. Use of transdermal estrogens in women has been shown to be safe [<a class="bk_pop" href="#hep.REF.bulaj.2000.482">Bulaj et al 2000</a>].</div></li><li class="half_rhythm"><div><b>Antioxidants.</b> Substantial reductions in plasma levels of ascorbate and carotenoids have been noted in some individuals with PCT [<a class="bk_pop" href="#hep.REF.percy.1975.185">Percy et al 1975</a>, <a class="bk_pop" href="#hep.REF.sinclair.1997.197">Sinclair et al 1997</a>, <a class="bk_pop" href="#hep.REF.rocchi.1999.861">Rocchi et al 1999</a>].</div></li></ul></div><div id="hep.Pathophysiology"><h3>Pathophysiology</h3><p>UROD deficiency (in all tissues) leads to the accumulation of substrate, uroporphyrinogen, and the intermediate products of the reaction in all cells. Cells with a high demand for heme production include the erythron and the hepatocyte, and thus, accumulation may be more pronounced in these cell types. The substrates and intermediates accumulate in cells in the form of oxidized porphyrins (mostly uroporphyrin and heptacarboxylporphyrin) that are then transported into the plasma and eventually into the urine. These excess porphyrins are deposited in the skin and other tissues. For more information about the proposed pathophysiology of HEP, click <a href="/books/NBK169003/bin/hep-pathophysiology.pdf">here</a>.</p></div><div id="hep.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clinically significant <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been found (see <a href="#hep.Molecular_Genetics">Molecular Genetics</a>).</p></div><div id="hep.Nomenclature"><h3>Nomenclature</h3></div><div id="hep.Prevalence"><h3>Prevalence</h3><p>Fewer than 100 cases of HEP have been reported in the literature. The frequency of HEP can only be inferred based on that of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> PCT, which occurs in one in 20,000.</p></div></div><div id="hep.Genetically_Related_Allelic_Disorder"><h2 id="_hep_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><a href="/books/n/gene/porphyria-ct/">Familial porphyria cutanea tarda</a> (F-PCT) is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>UROD</i>.</p></div><div id="hep.Differential_Diagnosis"><h2 id="_hep_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Type I porphyria cutanea tarda (<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>; no <i>UROD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>)</b>. Type I porphyria cutanea tarda (PCT) is highly influenced by susceptibility factors associated with PCT; often several are present in individuals with type I PCT, including a pathogenic variant in <i>HFE</i>. Type I PCT is clinically indistinguishable from HEP and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> PCT.</p><p><a href="/books/n/gene/porphyria-ct/"><b>Familial porphyria cutanea tarda</b></a>
<b>(F-PCT).</b> The skin lesions of F-PCT resemble those of HEP, however they are less severe. The skin changes of F-PCT typically begin later, in the fourth or fifth decade of life. Disease manifestations are more common in men than women. Because the laboratory findings in individuals with F-PCT and HEP can be clinically indistinguishable at the time of diagnosis, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is necessary to discriminate between these two disorders. Measurement of UROD enzyme activity is not an accurate method to distinguish between F-PCT and HEP. Heterozygous <i>UROD</i> pathogenic variants are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><a href="/books/n/gene/porphyria-var/"><b>Variegate porphyria</b></a>
<b>(VP) and</b>
<a href="/books/n/gene/hcp/"><b>hereditary coproporphyria</b></a>
<b>(HCP).</b> Blistering skin lesions in VP and HCP are nearly identical to those in HEP. Although the cutaneous manifestations of HEP are also chronic and blistering, they are usually more severe than those of VP because circulating porphyrin levels are usually much higher (by an order of magnitude) than in VP. HCP is generally accompanied by neurovisceral features, especially bouts of severe abdominal pain, which are not observed in HEP. In both HCP and VP, the principal source of overproduction of heme precursors is the liver. VP is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PPOX</i> and HCP is caused by a heterozygous pathogenic variant in <i>CPOX</i>. Both disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with low <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Although mild manifestations of HEP can be mistaken for those of VP and HCP, the erythropoietic porphyrias (e.g., HEP, CEP, or EPP) are differentiated particularly by the presence of high levels of erythrocyte porphyrins.</p><p><a href="/books/n/gene/cep/"><b>Congenital erythropoietic porphyria</b></a>
<b>(CEP).</b> The skin lesions of CEP, like those seen in HEP, appear early in life (i.e., in infancy or childhood) and are severe and mutilating. In both CEP and HEP the increased severity is attributed to the plasma concentration of porphyrin. Although CEP can be mistaken for HEP, urine porphyrin analysis (which demonstrates uroporphyrin and coproporphyrin type I) rules out other types of cutaneous porphyria. Fecal analysis may be necessary, particularly for late-onset cases. CEP caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>UROS</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner; CEP caused by a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GATA1</i> (rare) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p><b>Pseudoporphyria.</b> Although the skin histopathologic findings of pseudoporphyria are indistinguishable from those of HEP, pseudoporphyria does not cause porphyrin biochemical abnormalities. Drugs are implicated in the appearance of this condition [<a class="bk_pop" href="#hep.REF.barzilay.2001.195">Barzilay et al 2001</a>].</p></div><div id="hep.Management"><h2 id="_hep_Management_">Management</h2><div id="hep.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with hepatoerythropoietic porphyria (HEP), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation for excess hepatic iron</div></li><li class="half_rhythm"><div>Targeted analysis for <i>HFE</i> pathogenic variants (see <a href="/books/n/gene/hemochromatosis/"><i>HFE</i> hemochromatosis</a>)</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hep.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There are no effective treatment regimens to restore enzyme levels in individuals with HEP. Hence, treatment recommendations at this time are similar to the ones for <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda (<a href="/books/n/gene/porphyria-ct/">F-PCT</a>): the avoidance of sunlight, including the long-wave ultraviolet light sunlight that passes through window glass.</p></div><div id="hep.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>The following measures are recommended:</p><ul><li class="half_rhythm"><div>Protection from sunlight because of the high risk for severe skin damage and possible mutilation</div></li><li class="half_rhythm"><div>Identification and avoidance of susceptibility factors (where applicable) . See <a href="#hep.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>.</div></li><li class="half_rhythm"><div>Avoidance of drugs and agents that induce the hepatic P450</div></li><li class="half_rhythm"><div>Vaccination against hepatitis A and B</div></li></ul></div><div id="hep.Surveillance"><h3>Surveillance</h3><p>There are currently no recommendations or guidelines for surveillance in those with HEP.</p></div><div id="hep.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Persons of all ages should avoid exposure to sunlight.</p><p>Older individuals should avoid the known precipitating factors (e.g., alcohol, oral estrogen, smoking, and drugs that induce the cytochrome P450s).</p></div><div id="hep.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If the family-specific <i>UROD</i> pathogenic variants are known, it is reasonable to clarify the genetic status of at-risk relatives so that those with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>UROD</i> pathogenic variants can be counseled regarding sun protection and avoidance of known susceptibility factors.</p><p>See <a href="#hep.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hep.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="hep.Genetic_Counseling"><h2 id="_hep_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hep.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Hepatoerythropoietic porphyria (HEP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="hep.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes.</div></li><li class="half_rhythm"><div>Heterozygotes have <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda (<a href="/books/n/gene/porphyria-ct/">F-PCT</a>) but are generally asymptomatic because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. If susceptibility factors, including excess hepatic iron, <i>HFE</i> pathogenic variants, alcohol consumption, infection with hepatitis C, oral estrogen use, and smoking are present, heterozygotes are at increased risk of developing signs and symptoms of F-PCT (see <a href="#hep.Clinical_Description">Clinical Description</a> and <a href="#hep.Differential_Diagnosis">Differential Diagnosis</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of having HEP, a 50% chance of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (and an increased risk of developing F-PCT), and a 25% chance of being unaffected.</div></li><li class="half_rhythm"><div>Heterozygotes have F-PCT but are generally asymptomatic because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. If susceptibility factors are present, heterozygotes are at increased risk of developing signs and symptoms of F-PCT.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with HEP are obligate heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>UROD</i>.</div></li><li class="half_rhythm"><div>Heterozygotes have F-PCT but are generally asymptomatic because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. If susceptibility factors are present, heterozygotes are at increased risk of developing signs and symptoms of F-PCT.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of having a <i>UROD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being at increased risk of developing signs and symptoms of F-PCT.</p></div><div id="hep.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#hep.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who have HEP.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hep.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>UROD</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HEP are possible.</p></div></div><div id="hep.Resources"><h2 id="_hep_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Porphyria Foundation (APF)</b></div><div>915 St. Elmo Avenue</div><div>Suite 200</div><div>Bethesda MD 20814</div><div><b>Phone:</b> 866-APF-3635 (toll-free); 301-347-7166</div><div><b>Email:</b> porphyrus@porphyriafoundation.com</div><div><a href="https://www.porphyriafoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.porphyriafoundation.org</a></div></li><li class="half_rhythm"><div><b>European Porphyria Network</b></div><div><b>Email:</b> contact@porphyria.eu</div><div><a href="http://porphyria.eu/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">porphyria.eu</a></div></li><li class="half_rhythm"><div><b>Swedish Porphyria Patients' Association</b></div><div>Karolinska Universitetssjukhuset</div><div>Huddinge M 96</div><div>Stockholm Stockholms Lan SE-141 86</div><div>Sweden</div><div><b>Phone:</b> +46 8 711 56 09 </div><div><b>Email:</b> porfyrisjukdomar@gmail.com</div><div><a href="http://www.porfyri.se" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.porfyri.se</a></div></li></ul></div><div id="hep.Molecular_Genetics"><h2 id="_hep_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hep.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hepatoerythropoietic Porphyria: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169003/table/hep.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hep.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hep.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hep.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hep.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hep.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hep.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hep.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hep.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7389" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>UROD</i></a></td><td headers="hd_b_hep.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7389" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p34<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hep.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P06132" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Uroporphyrinogen decarboxylase</a></td><td headers="hd_b_hep.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/UROD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UROD database</a></td><td headers="hd_b_hep.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=UROD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UROD</a></td><td headers="hd_b_hep.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=UROD[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UROD</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hep.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hep.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hepatoerythropoietic Porphyria (<a href="/omim/176100,613521" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169003/table/hep.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hep.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PORPHYRIA CUTANEA TARDA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613521" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613521</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UROPORPHYRINOGEN DECARBOXYLASE; UROD</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <i>UROD</i> transcript reference sequence <a href="/nuccore/NM_000374.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000374.4</a> has ten exons.</p><p><b>Pathogenic variants.</b> At least 70 different <i>UROD</i> pathogenic variants have been identified in HEP and in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porphyria cutanea tarda (<a href="/books/n/gene/porphyria-ct/">F-PCT</a>).</p><ul><li class="half_rhythm"><div>In F-PCT <i>UROD</i> pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (the most common), <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; several small and large deletions; and small insertions [<a class="bk_pop" href="#hep.REF.anderson.2000">Anderson et al 2000</a>].</div></li><li class="half_rhythm"><div>In HEP, a similar variety of <i>UROD</i> pathogenic variants have been identified. With few exceptions, the <i>UROD</i> pathogenic variants identified in HEP have not been found in F-PCT.</div></li></ul><p>In HEP, at least one of the mutated <i>UROD</i> alleles must preserve some degree of catalytic activity.</p><p>Homozygosity for <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles is lethal [<a class="bk_pop" href="#hep.REF.phillips.2007.5079">Phillips et al 2007</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> has been described in Norway [<a class="bk_pop" href="#hep.REF.aarsand.2009.795">Aarsand et al 2009</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein encoded by the reference transcript has 367 amino acids (<a href="/protein/NP_000365.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000365.3</a>) (see <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=1URO" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">protein structure</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Hepatic uroporphyrinogen decarboxylase enzyme activity less than approximately 20% of normal results in disease.</p></div><div id="hep.References"><h2 id="_hep_References_">References</h2><div id="hep.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hep.REF.aarsand.2009.795">Aarsand AK, Boman H, Sandberg S. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. <span><span class="ref-journal">Clin Chem. </span>2009;<span class="ref-vol">55</span>:795–803.</span> [<a href="/pubmed/19233912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19233912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.anderson.2000">Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B, eds. <em>The Metabolic &#x00026; Molecular Bases of Inherited Disease</em>. 8 ed. New York, NY: McGraw-Hill; 2000:2961-2.</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.barzilay.2001.195">Barzilay D, Orion E, Brenner S. Porphyria cutanea tarda triggered by a combination of three predisposing factors. <span><span class="ref-journal">Dermatology. </span>2001;<span class="ref-vol">203</span>:195–7.</span> [<a href="/pubmed/11586030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11586030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.bonkovsky.2013">Bonkovsky HL, Guo J-T, Hou W, Li T, Narang T, Thapar M. Porphyrin and heme metabolism and the porphyrias. In: Omary B, Lu SC-L, Wolkoff A, eds. <em>Comprehensive Physiology</em>. Bethesda, MD: American Physiological Society, Wiley-Blackwell; 2013:365-401.</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.bulaj.2000.482">Bulaj ZJ, Franklin MR, Phillips JD, Miller KL, Bergonia HA, Ajioka RS, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP. Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda. <span><span class="ref-journal">J Lab Clin Med. </span>2000;<span class="ref-vol">136</span>:482–8.</span> [<a href="/pubmed/11128750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11128750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.cantatorefrancis.2010.529">Cantatore-Francis JL, Cohen-Pfeffer J, Balwani M, Kahn P, Lazarus HM, Desnick RJ, Schaffer JV. Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation. <span><span class="ref-journal">Arch Dermatol. </span>2010;<span class="ref-vol">146</span>:529–33.</span> [<a href="/pmc/articles/PMC3092549/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3092549</span></a>] [<a href="/pubmed/20479301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20479301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.de_verneuil.1992.548">de Verneuil H, Bourgeois F, de Rooij F, Siersema PD, Wilson JH, Grandchamp B, Nordmann Y. Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria. <span><span class="ref-journal">Hum Genet. </span>1992;<span class="ref-vol">89</span>:548–52.</span> [<a href="/pubmed/1634232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1634232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.egger.2002.419">Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. <span><span class="ref-journal">Dig Dis Sci. </span>2002;<span class="ref-vol">47</span>:419–26.</span> [<a href="/pubmed/11855561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11855561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.elder.1997.237">Elder GH. Hepatic porphyrias in children. <span><span class="ref-journal">J Inherit Metab Dis. </span>1997;<span class="ref-vol">20</span>:237–46.</span> [<a href="/pubmed/9211196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9211196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.grossman.1979.277">Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. <span><span class="ref-journal">Am J Med. </span>1979;<span class="ref-vol">67</span>:277–86.</span> [<a href="/pubmed/463934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 463934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.mendez.1998.1363">Mendez M, Sorkin L, Rossetti MV, Astrin KH. del C Batlle AM, Parera VE, Aizencang G, Desnick RJ. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1363–75.</span> [<a href="/pmc/articles/PMC1377546/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377546</span></a>] [<a href="/pubmed/9792863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9792863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.mu_ozsantos.2010.69">Mu&#x000f1;oz-Santos C, Guilabert A, Moreno N, To-Figueras J, Badenas C, Darwich E, Herrero C. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. <span><span class="ref-journal">Medicine (Baltimore). </span>2010;<span class="ref-vol">89</span>:69–74.</span> [<a href="/pubmed/20517178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20517178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.percy.1975.185">Percy VA, Naidoo D, Joubert SM, Pegoraro RJ. Ascorbate status of patients with porphyria cutanea tarda symptomatic and its effect on porphyrin metabolism. <span><span class="ref-journal">S Afr J Med Sci. </span>1975;<span class="ref-vol">40</span>:185–96.</span> [<a href="/pubmed/1209393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1209393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.phillips.2007.5079">Phillips JD, Bergonia HA, Reilly CA, Franklin MR, Kushner JP. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:5079–84.</span> [<a href="/pmc/articles/PMC1820519/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1820519</span></a>] [<a href="/pubmed/17360334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17360334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.pohfitzpatrick.1976.362">Poh-Fitzpatrick MB, Lamola AA. Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias. <span><span class="ref-journal">J Lab Clin Med. </span>1976;<span class="ref-vol">87</span>:362–70.</span> [<a href="/pubmed/1245797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1245797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.rocchi.1999.861">Rocchi E, Casalgrandi G, Masini A, Giovannini F, Ceccarelli D, Ferrali M, Marchini S, Ventura E. Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders. <span><span class="ref-journal">Ital J Gastroenterol Hepatol. </span>1999;<span class="ref-vol">31</span>:861–7.</span> [<a href="/pubmed/10669994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10669994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.ryan_caballes.2012.880">Ryan Caballes F, Sendi H, Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. <span><span class="ref-journal">Liver Int. </span>2012;<span class="ref-vol">32</span>:880–93.</span> [<a href="/pmc/articles/PMC3418709/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3418709</span></a>] [<a href="/pubmed/22510500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22510500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.sinclair.1997.197">Sinclair PR, Gorman N, Shedlofsky SI, Honsinger CP, Sinclair JF, Karagas MR, Anderson KE. Ascorbic acid deficiency in porphyria cutanea tarda. <span><span class="ref-journal">J Lab Clin Med. </span>1997;<span class="ref-vol">130</span>:197–201.</span> [<a href="/pubmed/9280147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9280147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hep.REF.sixeldietrich.1985.13">Sixel-Dietrich F, Doss M. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. <span><span class="ref-journal">Arch Dermatol Res. </span>1985;<span class="ref-vol">278</span>:13–6.</span> [<a href="/pubmed/4096525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4096525</span></a>]</div></li></ul></div></div><div id="hep.Chapter_Notes"><h2 id="_hep_Chapter_Notes_">Chapter Notes</h2><div id="hep.Acknowledgments"><h3>Acknowledgments</h3><p>On behalf of the Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network; including Dr Karl Anderson, University of Texas Medical Branch, Galveston, TX; Dr Montgomery Bissell, University of California, San Francisco, CA; Dr Herbert Bonkovsky, Wake Forest University School of Medicine and NC Baptist Medical Center, Winston-Salem, NC; Dr John Phillips, University of Utah School of Medicine, Salt Lake City, UT</p></div><div id="hep.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 December 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 October 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>26 April 2012 (hb) Original Submission</div></li></ul></div></div><div><dl class="temp-labeled-list small"><dt>*</dt><dd><div id="hep.Tb.an4"><p class="no_top_margin">See Chapter Notes, <a href="#hep.Acknowledgments">Acknowledgments</a>.</p></div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK169003</span><span class="label">PMID: <a href="/pubmed/24175354" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24175354</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vodi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ataxias/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK169003&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK169003/?report=reader">PubReader</a></li><li><a href="/books/NBK169003/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK169003" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK169003" style="display:none" title="Cite this Page"><div class="bk_tt">Liu LU, Phillips J, Bonkovsky H; Porphyrias Consortium of the Rare Diseases Clinical Research Network. Hepatoerythropoietic Porphyria. 2013 Oct 31 [Updated 2016 Dec 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK169003/pdf/Bookshelf_NBK169003.pdf">PDF version of this page</a> (405K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hep.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hep.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hep.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hep.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hep.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hep.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hep.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hep.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hep.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hep.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hep.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7389[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">UROD</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3077[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HFE</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3058888" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3058888" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3058888" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3058888" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23741761" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Porphyria Cutanea Tarda</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Porphyria Cutanea Tarda<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu LU, Phillips J, Bonkovsky H, Porphyrias Consortium of the Rare Diseases Clinical Research Network. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24027798" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Erwin A, Balwani M, Desnick RJ, Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23409300" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Variegate Porphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Variegate Porphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Singal AK, Anderson KE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30514647" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.</a><span class="source">[Mol Genet Metab. 2019]</span><div class="brieflinkpop offscreen_noflow">Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Weiss Y, Chen B, Yasuda M, Nazarenko I, Anderson KE, Desnick RJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2019 Nov; 128(3):363-366. Epub 2018 Nov 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23409301" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Protoporphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Protoporphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balwani M, Desnick R, Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24175354" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24175354" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413acdd21425a25c9f5f2">Hepatoerythropoietic Porphyria - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hepatoerythropoietic Porphyria - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:58:04-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AFD22E03FC7110000000009290310&amp;ncbi_session=CE8AFD22E0413AB1_2345SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK169003%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK169003&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK169003/&amp;ncbi_pagename=Hepatoerythropoietic Porphyria - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AFD22E0413AB1_2345SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>